MJC13

MJC13 is an FKBP52-targeted agent with anti-tumor activity that can be used in prostate cancer research[1].

Product Specifications

CAS Number

[200709-97-3]

UNSPSC

12352005

Hazard Statement

H302-H319

Target

FKBP

Related Pathways

Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation

Field of Research

Cancer

Smiles

C1CCC(CC1)C(=O)NC2=C(C(=CC=C2)Cl)Cl

Molecular Formula

C13H15Cl2NO

Molecular Weight

272.17

Precautions

P264-P270-P280-P330-P501

References & Citations

[1]Su Liang, et al. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016;21 (1) :121-6.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PH37323M5 20 µg

FNTA (NM_002027) Human Recombinant Protein

Ask

View Details

bs-7810R-PE-Cy7 100 µL

MFAP1 Polyclonal Antibody, PE-Cy7 Conjugated

Ask

View Details

GTR15150297 1 Vial

Lentiviral human EIF2B1 shRNA (UAS) - Lentiviral human EIF2B1 shRNA (UAS, GFP) (100)

Ask

View Details

TL706177V 500 µL Each

Arid5b Rat shRNA Lentiviral Particle (Locus ID 309728)

Ask

View Details

GTR15087198 1 Vial

Lentiviral human FBXL12 shRNA (UAS) - Lentiviral human FBXL12 shRNA (UAS) (100)

Ask

View Details

TA327734 1 mL

S100P Rabbit Monoclonal Antibody [Clone ID: EP1840Y]

Ask

View Details